Canaccord lowered the firm’s price target on Aspen Aerogels (ASPN) to $20 from $28 and keeps a Buy rating on the shares. The firm adjusted its model to capture some of the uncertainties ahead yet values it a premium to peers based on its strong growth potential beyond 2027 through its numerous OEM relationships, competitive moat, strong balance sheet, and potential for healthy FCF generation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN: